Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Interest & Investment Income of $297000.0 in Q1 2026, down 30.44% on a QoQ basis from $427000.0 in Q4 2025, and down 7.76% year-over-year from $322000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Interest & Investment Income across 17 years of filings, most recently posting $297000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 7.76% year-over-year to $297000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 36.36% YoY) and the FY2025 annual result came in at $1.5 million, down 36.54% from the prior year.
- Interest & Investment Income fell to $297000.0 in Q1 2026, from $427000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $833000.0 in Q2 2024 and troughed at $4000.0 in Q1 2022.
- A 5-year average of $304235.3 and a median of $262000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 4725.0% — and 2025, when it plunged 76.95%.
- Tracing ACHV's Interest & Investment Income over 5 years: stood at $118000.0 in 2022, then soared by 76.27% to $208000.0 in 2023, then soared by 131.73% to $482000.0 in 2024, then declined by 11.41% to $427000.0 in 2025, then slumped by 30.44% to $297000.0 in 2026.
- Business Quant data shows ACHV's Interest & Investment Income at $297000.0 in Q1 2026, $427000.0 in Q4 2025, and $554000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | 297,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 297,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Sep 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |